Top

Reactions Weekly

Published in:

01-08-2023 | Osimertinib | Case report

Carboplatin/osimertinib/pemetrexed

Fever, diarrhoea and drug resistance: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Hao L, et al. Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small-cell lung cancer. Thoracic Cancer 14 : 1036-1041, No. 11, Apr 2023. Available from: URL: http://doi.org/10.1111/1759-7714.14832

Title: Carboplatin/osimertinib/pemetrexed
Fever, diarrhoea and drug resistance: case report
Publication date: 01-08-2023
Publisher: Springer International Publishing
Keywords: Osimertinib
Diarrhea
Diarrhea
Lung Cancer
Lung Cancer
Lung Cancer
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-44928-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Carboplatin/osimertinib/pemetrexed

Fever, diarrhoea and drug resistance: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Dimethyl-fumarate

Phenytoin/prednisolone

Immune-globulin/rituximab

Multiple drugs

Naphazoline/nivolumab

Asparaginase/pegaspargase